From Earlier: Covidien Announces FDA 510k Clearance and CE Mark for Nellcor Bedside Respiratory Patient Monitoring System

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.

Covidien (NYSE: COV), a leading global provider of healthcare products andrecognized innovator in patient monitoring and respiratory care devices, todayannounced U.S. Food and Drug Administration 510(k) clearance and EuropeanEconomic Area (EEA) CE Mark approval for the Covidien Nellcor^™ BedsideRespiratory Patient Monitoring system.

27% profit every 20 days?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!